Figure 4.
Regarding the biodegradation-susceptible of miRNAs and stem cells compared to other biomolecules in vivo, the in-situ injection is applied to enhance drug delivery efficacy. However, this approach decreases the possibility of clinical translation since the in-situ injection induces a second injury to the damaged fragile myocardium.